Name of Study:
Progesterone for Perimenopausal Hot Flushes and Night Sweats
Purpose of this study:
The purpose of this Canadian Institutes of Health Research (CIHR)-funded randomized controlled trial is to test whether oral micronized progesterone is more effective than placebo as therapy for hot flushes and night sweats in perimenopausal women.
Who can participate?
The study is open to perimenopausal women living anywhere in Canada who have menstruated within the past 12 months, have moderate-to-severe hot flushes (4 per day) and/or night sweats (waking twice weekly). Participants should not have used estrogen, progesterone, progestin or hormonal birth control within the past 6 months.
What is involved?
Study participation can be from home or in-person. Women will keep a daily record of hot flushes and night sweats during a baseline 4-weeks and 12-weeks of daily oral micronized progesterone or placebo.
When does this study take place?
Recruitment starts in the fall of 2011, and continues until November 2013.
Where does this study take place/location?
Participation from home or at Diamond Health Care Centre, 2775 Laurel St, 4th Floor. (12th and Oak, Vancouver.)
Dr Jerilynn C Prior, BA, MD, FRCPC
Centre for Menstrual Cycle and Ovulation Research (CeMCOR)
Division of Endocrinology, Department of Medicine
University of British Columbia and Vancouver Coastal Health Research Institute
CeMCOR – Oral Micronized Progesterone for Perimenopausal Hot Flushes
Andrea Cameron, Research Coordinator, 604 875 5960; toll-free 1 855 875 5960; study email: firstname.lastname@example.org
This recruiting service, provided by the VCH Research Institute, saves study coordinators thousands of dollars and helps VCH remain an effective clinical trials site. The effectiveness of these emails has been measured and validated by clinical trial coordinators as a very important and effective way of reaching potential study participants. We try to list the subject line in such a way that it can be easily deleted by those who are not interested.